Indication: EPIDUO® (adapalene and benzoyl peroxide) Gel, 0.1%/2.5% is indicated for the
topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In
controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated
with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site
irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid
exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided.
Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur
with use of EPIDUO® Gel and may necessitate discontinuation.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch or call 1‐800‐FDA‐1088.
©2014 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the
property of their respective owners. This site intended for U.S. audiences only. Information in this
website is not intended as medical advice. Talk to your doctor about medical concerns.
Photo: © Jani Bryson/iStockphoto. Individual pictured is a model and is used for illustrative purposes ONLY.